P2X7 receptor and macrophage function

被引:43
作者
Wewers, Mark D. [1 ,2 ]
Sarkar, Anasuya [2 ]
机构
[1] Ohio State Univ, Davis Heart & Lung Res Inst 201, Columbus, OH 43210 USA
[2] Ohio State Univ, Davis Heart & Lung Res Inst, Div Pulm Allergy Crit Care & Sleep Med, Columbus, OH 43210 USA
关键词
Macrophage; IL-18; LPS; Priming; AG126; Tyrosine kinase; ALVEOLAR MACROPHAGES; INTERLEUKIN-1-BETA RELEASE; MONONUCLEAR PHAGOCYTES; ANTIMICROBIAL ACTIVITY; IL-1-BETA RELEASE; HUMAN MONOCYTES; PORE FORMATION; HUMAN-LUNG; ATP; CASPASE-1;
D O I
10.1007/s11302-009-9131-9
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Macrophages are unique innate immune cells that play an integral role in the defense of the host by virtue of their ability to recognize, engulf, and kill pathogens while sending out danger signals via cytokines to recruit and activate inflammatory cells. It is becoming increasingly clear that purinergic signaling events are essential components of the macrophage response to pathogen challenges and disorders such as sepsis may be, at least in part, regulated by these important sensors. The activation of the P2X(7) receptor is a powerful event in the regulation of the caspase-1 inflammasome. We provide evidence that the inflammasome activation requires "priming" of macrophages prior to ATP activation of the P2X(7)R. Inhibition of the inflammasome activation by the tyrosine kinase inhibitor, AG126, suggests regulation by phosphorylation. Finally, the P2X(7)R may also be activated by other elements of the host response such as the antimicrobial peptide LL-37, which adds a new, physiologically relevant agonist to the P2X(7)R pathway. Therapeutic approaches to inflammation and sepsis will certainly be enhanced by an increased understanding of how purinergic receptors modulate the inflammasomes.
引用
收藏
页码:189 / 195
页数:7
相关论文
共 50 条
  • [41] The P2X7 receptor and intracellular pathogens: a continuing struggle
    Coutinho-Silva, Robson
    Correa, Gladys
    Sater, Ali Abdul
    Ojcius, David M.
    PURINERGIC SIGNALLING, 2009, 5 (02) : 197 - 204
  • [42] Novel P2X7 receptor antagonists ease the pain
    King, B. F.
    BRITISH JOURNAL OF PHARMACOLOGY, 2007, 151 (05) : 565 - 567
  • [43] Emerging roles of the P2X7 receptor in cancer pain
    Wu, Ping
    Wang, Yin
    Liu, Yansong
    Liu, Yan
    Zhou, Guohua
    Wu, Xiaoqi
    Wen, Qingping
    PURINERGIC SIGNALLING, 2023, 19 (02) : 441 - 450
  • [44] Microglia: Proliferation and activation driven by the P2X7 receptor
    Monif, Mastura
    Burnstock, Geoffrey
    Williams, David A.
    INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2010, 42 (11) : 1753 - 1756
  • [45] Many ways to dilate the P2X7 receptor pore
    Pelegrin, Pablo
    BRITISH JOURNAL OF PHARMACOLOGY, 2011, 163 (05) : 908 - 911
  • [46] P2X7 is a cytotoxic receptor….maybe not: implications for cancer
    Francesco Di Virgilio
    Purinergic Signalling, 2021, 17 : 55 - 61
  • [47] P2X7 receptor as the regulator of T-cell function in intestinal barrier disruption
    Jiang, Zhi-Feng
    Wu, Wei
    Hu, Han-Bing
    Li, Zheng-Yang
    Zhong, Ming
    Zhang, Lin
    WORLD JOURNAL OF GASTROENTEROLOGY, 2022, 28 (36) : 5265 - 5279
  • [48] P2X7 Receptor at the Crossroads of T Cell Fate
    Rivas-Yanez, Elizabeth
    Barrera-Avalos, Carlos
    Parra-Tello, Brian
    Briceno, Pedro
    Rosemblatt, Mariana, V
    Saavedra-Almarza, Juan
    Rosemblatt, Mario
    Acuna-Castillo, Claudio
    Rosa Bono, Maria
    Sauma, Daniela
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (14) : 1 - 22
  • [49] C terminus of the P2X7 receptor: treasure hunting
    Costa-Junior, Helio Miranda
    Vieira, Flavia Sarmento
    Coutinho-Silva, Robson
    PURINERGIC SIGNALLING, 2011, 7 (01) : 7 - 19
  • [50] Expression, signaling, and function of P2X7 receptors in bone
    Grol, Matthew W.
    Panupinthu, Nattapon
    Korcok, Jasminka
    Sims, Stephen M.
    Dixon, S. Jeffrey
    PURINERGIC SIGNALLING, 2009, 5 (02) : 205 - 221